MITF and neoplasm: Finally, G‐protein‐coupled receptor/cAMP‐induced MITF upregulation confers MAPK pathway inhibitor resistance, and enhanced CREB phosphorylation is detected in tumours of relapsed patients (Johannessen et al., 2013).